Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | FID-007 |
| Synonyms | |
| Therapy Description |
FID-007 is composed of paclitaxel enclosed in a polyethyloxazoline (PEOX) polymer to enhance solubility, which potentially inhibits tumor growth (J Clin Oncol, 2013, 31:supplement 15, e13538). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| FID-007 | PEOX-based polymer encapsulated paclitaxel FID-007|FID007|Fid 007 | Chemotherapy - Taxane 3 | FID-007 is composed of paclitaxel enclosed in a polyethyloxazoline (PEOX) polymer to enhance solubility, which potentially inhibits tumor growth (J Clin Oncol, 2013, 31:supplement 15, e13538). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT03537690 | Phase I | FID-007 | FID-007 in Treating Participants With Advanced Solid Tumors | Active, not recruiting | USA | 0 |